PRN: Wearable Infusion Systems Global Report - Analysis, Prospects, Technologies & Forecasts - Key Vendors: CSL Behring, Roche, SteadyMed

23/mar/2016 14.10.21 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Wearable Infusion Systems Global Report - Analysis, Prospects, Technologies & Forecasts - Key Vendors: CSL Behring, Roche, SteadyMed

 
[23-March-2016]
 

DUBLIN, March 23, 2016 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/jrp8b2/wearable_infusion) has announced the addition of the "Wearable Infusion Systems" report to their offering. 

This report analyzes the wearable infusion systems, offering readers an unrivalled understanding of this market. It examines the technologies prevalent in the industry, and forecasts the opportunities this market offers.

The increasing number of drugs that must be infused is creating a new class of drug delivery devices - devices that can deliver therapeutic drugs in volumes up to 10 mL and higher to ambulatory patients. Wearable subcutaneous infusion systems are targeting the growing need for administering biologicals - a segment that includes monoclonal antibodies, immune modulators and blood factors - that are indicated for chronic conditions.

These devices distinguish themselves from syringes and injectors by delivering drug volumes in excess of 1-2 mL for durations that are measured in minutes rather than seconds. Several products in this device class have already reached the market, and recent agreements between device suppliers and pharma companies validate the market need that wearable infusion systems address. We expect wearable infusion systems to achieve and sustain double digit unit growth through the end of the decade. 

Questions Answered:

  • What wearable infusion systems are currently marketed or in development, who are the suppliers, and what are the device specifics?
  • What are the therapeutic markets being targeted by wearable infusion systems?
  • What are the essential design factors, material selection issues, technologies and market development issues for wearable infusion systems?
  • What are the major factors that will drive wearable infusion systems demand?
  • How are wearable infusion systems currently aligned with various drug classes and therapeutic markets?
  • What is the addressable market for wearable infusion systems?
  • What is the expected impact of wearable infusion systems on drug delivery markets?
  • Who are the significant players in this segment? What are their strategies? Who are their alliance partners?

Companies Mentioned:

  • CSL Behring
  • Ferring
  • Roche
  • SteadyMed
  • scPharmaceuticals

Report Structure:

1. Executive Summary Injectable/Infusible Market Segment Dynamics Drug Development Trends

2. Volumes and Viscosities

3. Wearable Infusion Systems - Commercial Devices

4. OEM Devices

5. Captive Devices

6. Single Product Devices

7. Wearable Infusions Systems - Near-Term Drug Products

8. Capricor

9. Wearable Infusion Therapeutics - The Addressable Market

10. Inflammatory Autoimmune Diseases

11. Market Factors

12. Self-Administration and Patient Compliance

13. Company Profiles

For more information visit http://www.researchandmarkets.com/research/jrp8b2/wearable_infusion

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

 

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl